logo
Plus   Neg
Share
Email

Danaher To Acquire Integrated DNA Technologies - Quick Facts

Danaher Corp. (DHR) has entered into a definitive agreement to acquire Integrated DNA Technologies or IDT, a privately-held provider of high-value consumables for genomics applications in molecular biology, qPCR, next generation sequencing, synthetic biology, gene editing and molecular diagnostics, the two companies said Friday.

Danaher is a manufacturer of professional, medical, industrial and commercial products. The transaction is expected to close mid-year 2018.

IDT's primary business is the manufacturing of custom DNA and RNA oligonucleotides or nucleic acid products serving customers in the academic and biopharmaceutical research, biotechnology, agriculture, clinical diagnostics, and pharmaceutical development end markets.

Founded in 1987 by Joseph Walder, IDT has grown to become a leader in its served markets with more than 1,200 employees and over 100,000 customers worldwide.
IDT will operate as a standalone operating company and brand within Danaher's Life Sciences platform.

Rainer Blair, Executive Vice President of Danaher's Life Sciences platform, said, "IDT expands our presence into the highly attractive genomics market and will help play a central role in accelerating our customers' research and time to market as they develop critical diagnostic tests and potential life-saving therapies. IDT's historical double-digit core revenue growth and strong margins are a testament to the team's commitment to the highest standards of quality, service, and technical expertise."

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Alibaba's founder and chairman Jack Ma has said that the Chinese e-commerce giant no longer plans to create 1 million jobs in the US, citing the ongoing trade conflict between the US and China as the reason. "The promise was made on the premise of friendly US-China partnership and rational trade relations,"... California's insurance regulator has filed a lawsuit against AbbVie Inc. for allegedly giving illegal kickbacks to health care providers to prescribe its arthritis drug Humira. The lawsuit filed in Alameda County Superior Court by the California Department of Insurance alleges that private insurers have paid out $1.2 billion in Humira-related pharmacy claims. Danske Bank A/S's Chief Executive Thomas Borgen resigned on Wednesday after the Danish lender announced the results of an internal probe relating to a money-laundering scandal in its branch in Estonia that involved payments of about 200 billion euros. Danske Bank said its investigation covered about 15,000 customers and a total of around 9.5 million payments through the branch.
Follow RTT